Reactive oxide species-scavenging lipid-polymer nanoparticles for neuroprotection after spinal cord injury

Suppression of secondary damage following traumatic spinal cord injury (SCI) remains a great challenge in the clinical treatment of acute SCI. To date, the most validated treatment in clinic is the use of antioxidants to reduce reactive oxygen species (ROS)-induced oxidative damage during the secondary injury process. However, clinically available antioxidants, such as methylprednisolone, commonly lead to modest improvement in neurological recovery and yet are accompanied with serious side effects. Herein, we report on the development of lipid-polymer nanoparticles (denoted as PELPNPs) with a high ROS-scavenging ability that effectively eliminated ROS and thus reduced long-term secondary injury in a clinically relevant rat SCI model. In vitro tests demonstrated that PELPNPs could readily scavenge overproduced ROS, reduce inflammation, and protect glial cells and neurons against H2O2 -induced oxidative damage. After intravenous administration, PELPNPs significantly improved the recovery of locomotor function and reduced the lesion area through effective protection of neurons and myelin sheaths. Mechanism studies proved that the superior therapeutic effect of PELPNPs was attributed to their high ROS scavenging and anti-inflammatory abilities. Thus, the proposed ROS-scavenging nanoparticle system shows promise for effective treatment of clinical SCI. (C) 2021 Elsevier Ltd. All rights reserved.

Automated summary

This study presents a novel lipid-polymer nanoparticle PELPNPs, which effectively scavenges ROS and reduces long-term secondary injury in a rat SCI model. PELPNPs show promise for effective treatment of clinical SCI by protecting neurons and myelin sheaths through ROS scavenging and anti-inflammatory abilities.